Lung Adenocarcinoma Latest Advances

Machine learning prognostic model and drug survival analysis for lung adenocarcinoma in the context of radiotherapy.

Journal: Pakistan journal of pharmaceutical sciences

Published: September 08, 2026

Synchronizing immunity and angiogenesis in lung adenocarcinoma: bridging biological synergy and clinical translation.

Journal: Cancer biology & therapy

Published: September 08, 2026

Corrigendum to "Comprehensive characterization of T cell subtypes in lung adenocarcinoma: Prognostic, predictive, and therapeutic implications" [Translational Oncology Volume 55, May 2025, 102332].

Journal: Translational oncology

Published: September 07, 2026

GJB2, a novel transcription target of HSF4, confers tumorigenic and metastatic phenotypes and sustains mitochondrial homeostasis in lung adenocarcinoma via the PI3K/AKT pathway.

Journal: Cell adhesion & migration

Published: September 06, 2026

CT-based cross-center risk stratification of pure ground-glass nodules incorporating domain style-aware correction.

Journal: Acta radiologica (Stockholm, Sweden : 1987)

Published: September 03, 2026

Glutamine stress promotes metastatic potential via hexosamine biosynthetic pathway activity in KRAS/STK11-mutant lung adenocarcinoma.

Journal: Research square

Published: September 03, 2026

Pulmonary Adenocarcinoma Arising From Somatic-type Malignant Transformation of a Nonseminomatous Germ Cell Tumor: A Case Report.

Journal: Journal of investigative medicine high impact case reports

Published: September 03, 2026

Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response.

Journal: Biomaterials science

Published: September 01, 2026

Correction: ANP32E drives lung adenocarcinoma progression via GSK3β-mediated glycolytic reprogramming.

Journal: Cell death & disease

Published: August 31, 2026

SHMT2: a Metabolic and Immune Biomarker of Aggressive Lung Adenocarcinoma.

Journal: Journal of visualized experiments : JoVE

Published: August 29, 2026

Correction to "Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF-κB pathway".

Journal: Cancer science

Published: August 28, 2026

Semi-Supervised Domain Adaptation with Latent Diffusion for Pathology Image Classification.

Journal: IEEE journal of biomedical and health informatics

Published: August 27, 2026

Lung Adenocarcinoma Latest Advances

Find the Latest Research About Lung Adenocarcinoma

Machine learning prognostic model and drug survival analysis for lung adenocarcinoma in the context of radiotherapy.

Machine learning prognostic model and drug survival analysis for lung adenocarcinoma in the context of radiotherapy.

Synchronizing immunity and angiogenesis in lung adenocarcinoma: bridging biological synergy and clinical translation.

Synchronizing immunity and angiogenesis in lung adenocarcinoma: bridging biological synergy and clinical translation.

Corrigendum to "Comprehensive characterization of T cell subtypes in lung adenocarcinoma: Prognostic, predictive, and therapeutic implications" [Translational Oncology Volume 55, May 2025, 102332].

Corrigendum to "Comprehensive characterization of T cell subtypes in lung adenocarcinoma: Prognostic, predictive, and therapeutic implications" [Translational Oncology Volume 55, May 2025, 102332].

GJB2, a novel transcription target of HSF4, confers tumorigenic and metastatic phenotypes and sustains mitochondrial homeostasis in lung adenocarcinoma via the PI3K/AKT pathway.

GJB2, a novel transcription target of HSF4, confers tumorigenic and metastatic phenotypes and sustains mitochondrial homeostasis in lung adenocarcinoma via the PI3K/AKT pathway.

CT-based cross-center risk stratification of pure ground-glass nodules incorporating domain style-aware correction.

CT-based cross-center risk stratification of pure ground-glass nodules incorporating domain style-aware correction.

Glutamine stress promotes metastatic potential via hexosamine biosynthetic pathway activity in KRAS/STK11-mutant lung adenocarcinoma.

Glutamine stress promotes metastatic potential via hexosamine biosynthetic pathway activity in KRAS/STK11-mutant lung adenocarcinoma.

Pulmonary Adenocarcinoma Arising From Somatic-type Malignant Transformation of a Nonseminomatous Germ Cell Tumor: A Case Report.

Pulmonary Adenocarcinoma Arising From Somatic-type Malignant Transformation of a Nonseminomatous Germ Cell Tumor: A Case Report.

Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response.

Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response.

Correction: ANP32E drives lung adenocarcinoma progression via GSK3β-mediated glycolytic reprogramming.

Correction: ANP32E drives lung adenocarcinoma progression via GSK3β-mediated glycolytic reprogramming.

SHMT2: a Metabolic and Immune Biomarker of Aggressive Lung Adenocarcinoma.

SHMT2: a Metabolic and Immune Biomarker of Aggressive Lung Adenocarcinoma.

Correction to "Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF-κB pathway".

Correction to "Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF-κB pathway".

Semi-Supervised Domain Adaptation with Latent Diffusion for Pathology Image Classification.

Semi-Supervised Domain Adaptation with Latent Diffusion for Pathology Image Classification.